ArticleInternational journal of chronic obstructive pulmonary disease2008
Determinants and predictors of the cost of COPD in primary care: a Spanish perspective.
Article in International journal of chronic obstructive pulmonary disease, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Cost of illness of non-communicable diseases in private and public health facilities in Nigeria: a qualitative and quantitative approach.The Pan African medical journal · 2023Article
- Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain.International journal of chronic obstructive pulmonary disease · 2021Observational
- Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India.PharmacoEconomics - open · 2020Article
- Economic impact of delaying initiation with multiple-inhaler maintenance triple therapy in Spanish patients with chronic obstructive pulmonary disease.International journal of chronic obstructive pulmonary disease · 2019Observational
- Insights about the economic impact of chronic obstructive pulmonary disease readmissions post implementation of the hospital readmission reduction program.Current opinion in pulmonary medicine · 2018Review
- A Cross-sectional Assessment of Health-related Quality of Life among Patients with Chronic Obstructive Pulmonary Disease.Iranian journal of public health · 2017Article
- Estimating the economic consequences of an increased medication adherence due to a potential improvement in the inhaler technique with SpiromaxClinicoEconomics and outcomes research : CEOR · 2017Article
- The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries.BMC health services research · 2016Article
- The value of coronary artery calcium score in the early diagnosis of coronary artery disease in patients with stable chronic obstructive pulmonary disease.Anatolian journal of cardiology · 2016Observational
- Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.International journal of chronic obstructive pulmonary disease · 2016Observational
- Comorbidities associated with COPD in the Middle East and North Africa region: association with severity and exacerbations.International journal of chronic obstructive pulmonary disease · 2016Article
- Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.International journal of chronic obstructive pulmonary disease · 2016Article
- Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol.NPJ primary care respiratory medicine · 2015Observational
- Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.International journal of chronic obstructive pulmonary disease · 2015Article
- Observational
- The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data.International journal of chronic obstructive pulmonary disease · 2013Article
- The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings.BMC cardiovascular disorders · 2010Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectives1) To estimate the annual cost of patients with stable chronic obstructive pulmonary disease (COPD) followed in primary care in Spain; 2) To analyze the possible cost predictor variables. PATIENTS AND
methodsA multicenter, epidemiological, observational, descriptive study. Sociodemographic data, severity of disease, associated comorbidity, treatment followed by patients, quality of life (SF-12 questionnaire), health care resource utilization in the previous 12 months and duration of working disability due to COPD were collected.
resultsA total of 10,711 patients (75.6% men; 24.4% women) with a mean age of 67.1 +/- 9.66 years were evaluated. The mean forced expiratory volume in one second (FEV1) value was 57.4 +/- 13.4%. The total cost per patient per year was Euro1,922.60 +/- 2,306.44. The largest component of this cost was hospitalization (Euro788.72 +/- 1,766.65), followed by cost of drugs (Euro492.87 +/- 412.15) and visits to emergency rooms (Euro134.32 +/- 195.44). Linear regression analysis found associated heart disease, FEV1, physical component of quality of life, number of medical visits (primary care physician, pneumologist and emergency room), hospital admissions (frequency and duration of stay) and duration of working disability to be significant predictors of the total annual cost.
conclusionsThe total annual cost of a COPD patient followed in primary care in Spain was considered high in this study. The presence of associated heart disease, severity of airflow obstruction, physical component of quality of life, health care resource utilization and duration of work disability were found to be predictor of cost.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.